PG
MDT icon

Pendal Group’s Medtronic MDT Stock Holding History

Pendal Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,923,852
Closed -$357M – 457
2019
Q1 		$357M Buy
+3,923,852
New +$351M 4.91% 2

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pendal Group's MDT Position: Q4 2022 in Review

Pendal Group reduced its Medtronic (MDT) stake by 29% in Q4 2022, selling an estimated $378K and leaving 11,578 shares worth $900K. The position accounts for 0.01% of the portfolio, ranked #309.

Pendal Group first reported a position in MDT in Q2 2017 and has held it in 23 quarters since. The position peaked at $492M in Q4 2020. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Pendal Group held 11,578 shares of Medtronic worth $900K as of Q4 2022.
  • Pendal Group sold 4,660 Medtronic shares in Q4 2022, an estimated $378K.
  • Medtronic made up 0.01% of Pendal Group's portfolio in Q4 2022, its #309 holding.
  • Pendal Group first reported a position in Medtronic in Q2 2017 and has held it in 23 quarters since.
  • Pendal Group's Medtronic position peaked at $492M in Q4 2020.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.